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ABSTRACT
The immune system may be considered as a sensory 
organ able to respond to different kinds of danger signals 
that are not detected by nervous cells. The immune 
response is not autonomous but also regulated by the cen-
tral and peripheral nervous system, as well as by neuropep-
tides, vitamin D and neuroendocrine axes such as the cor-
ticotrope, somatotrope, thyrotrope and gonadotrope axes. 
During evolution, the thymus emerged concomitantly with 
recombinase-dependent adaptive immunity as an ‘immune 
brain’ or a ‘master class’ highly specialized in the orchestra-
tion of central immunological self-tolerance. This was an 
absolute requirement for survival of species because of the 
high risk of autotoxicity inherent to the stochastic genera-
tion of extreme diversity characterizing this novel adaptive 
type of immune defenses against non-self. The thymus 
now appears to be an obligatory intersection for the inte-
grated evolution of the major systems of cell-to-cell signal-
ling, the nervous, endocrine and immune systems. The 
presentation of many self-peptides by thymic major histo-
compatibility complex (MHC) proteins is controlled by the 
autoimmune regulator (AIRE) gene/protein and is respon-
sible for the clonal deletion of self-reactive T cells. In the 
same time, by still unexplained mechanisms, MHC presen-
tation of the same self-peptides in the thymus promotes 
the generation of self-specific FOXP3+ CD4+CD25+ natural 
regulatory T cells (nTreg) that are able to inhibit in periph-
ery self-reactive CD4+ and CD8+ T cells having escaped the 
thymus censorship. Moreover, a thymus dysfunction is 
more and more established as the primary event driving 
the development of organ-specific autoimmunity, which is 
the tribute paid, mainly by mankind, for the preservation of 
self against non-self. Our novel knowledge about thymus 
physiology and physiopathology already serves as the 
basis for the development of various innovative and effi-
cient immunomodulating strategies in pharmacology.
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REVIEW
Galen (129 – 210 or 216 AD) first described an organ 
located behind the sternum that he named ‘thymus’ because 
of its close resemblance with a leaf of the thyme plant. For 
Galen, the thymus was the ‘seat of soul, eagerness, and forti-
tude’, and this old misconception most probably explains why 
some terms like ‘troubles thymiques’ are still used in the French 
medical language to designate mood disorders such as those 
observed in unipolar and bipolar depressive diseases. Jaco-
bus Berengarius Carpensis (1460-1530) then provided the first 
complete anatomical description of the thymus in his work 
entitled ‘Anatomia Carpi. Isagoge breves perlucide ac uberime, 
in anatomiam humani corporis’.
For a very long time, the thymus was considered as a use-
less vestigial organ that had become redundant during both 
phylogeny and human ontogeny after puberty. It is only in 
the early 1900s’ that the first ‘thymologist’ J. August Hammar 
initiated in Sweden biomedical research focusing on this 
organ (1). His pioneering work was followed by numerous 
studies that have highlighted the important neuroendocrine 
regulation of the thymus, in particular by the hypothalamo-
hypophysial axis, thyroid hormones, adrenal and sex steroids. 
For a long time, the thymus was considered as a gland and an 
intrinsic component of the endocrine system until the eluci-
dation of its fundamental role in immunity (2). Starting from 
1959, one can distinguish the following milestones leading to 
our current knowledge in thymus physiology:
•	 Role of the thymus in mouse leukaemia and in T-cell 
development (3, 4).
•	 Developmental biology of and self-recognition by dif-
ferentiating T cells in the thymus (5, 6).
•	 Promiscuous expression by thymus epithelium of 
genes encoding neuroendocrine-related and periph-
eral tissue-restricted antigens (7-11).
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jawless vertebrates (agnathans), and were mediated by 
diverse variable lymphocyte receptors (VLR), with 4-12 leu-
cine-rich repeat modules assembled by a gene conversion 
process. Some 450-500 million years ago, the emergence of 
transposon-like recombination activating genes rAG1 and 
rAG2 in jawed vertebrates (gnathostomes) promoted the 
development of adaptive immunity (20-22). The appearance 
of rAG1 and rAG2 in the genome of jawed vertebrates (most 
putatively via horizontal transmission), and the subsequent 
appearance of the combinatorial immune system, has some-
times been assimilated to the immunology’s ‘Big Bang’. Gene 
recombination in somatic lymphoid cells is responsible for 
the random generation of diverse immune receptors for anti-
gens, B-cell- (± 5 × 1013 BCR combinations) and T-cell recep-
tors (± 1018 TCR combinations). Because of its inherent risk of 
•	 Identification of the autoimmune regulatory (Aire) 
gene/protein as a transcription-like factor controlling 
promiscuous gene expression in thymus epithelium 
(12, 13). 
•	 Intrathymic selection of self-antigen specific natural 
regulatory T cells (nTreg) (14-16).
•	 Embryology of the thymus and deciphering of the 
lympho-stromal interactions required for T-cell differ-
entiation in the primary lymphoid organ (17-19).
In all living species, the neuroendocrine and innate 
immune systems have evolved in parallel and still coexist 
without any apparent problem (Fig. 1). Indeed, Toll-like recep-
tors (TLR) that are the most important mediators of innate 
immunity do not have the capacity of reaction against normal 
self. Some anticipatory immune responses already existed in 
Figure 1:  Integrated evolution of the neuroendocrine system, innate and rAG-dependent immunity.
 essential components of the neuroendocrine system have been established long ago and did not display important variation during 
evolution besides gene duplication or differential rnA splicing. the appearance of rAG-dependent adaptive immunity in jawed verte-
brates was associated with a high risk of autotoxicity directed against the neuroendocrine system. of note, from ancestor lamprey thy-
moids, the first unique thymus emerged quite concomitantly in jawed fishes, and the intrathymic presentation of neuroendocrine-related 
genes may be viewed a posteriori as a very efficient and economic way in instructing the adaptive t-cell system to tolerate neuroendocrine 
antigens as early as during intrathymic t-cell development and differentiation. 
 VCBp: variable-region-containing chitin-binding protein; Vlr: variable lymphocyte receptor; tCr: t-cell receptor.
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 proteins. Finally, for some of them, their transcription in the 
thymus precedes their eutopic expression in neuroendocrine 
glands (32). 
This hierarchy in the organization of the thymic repertoire 
of neuroendocrine self-antigens is also significant from an 
evolutionary point of view. Since many major physiological 
functions had been established before the emergence of the 
anticipatory adaptive immune response in jawless fishes, they 
had to be protected from the risk of autoimmunity inherent 
to this type of immune lottery. Oxytocin is a hypothalamic 
neuropeptide that is closely implicated at different steps of 
the reproductive process, starting from social affiliation and 
bonding to control of parturition and lactation. Thus, this 
neuropeptide is fundamental for preservation of animal and 
human species. Through its dominant expression in thymus 
epithelium, oxytocin is more tolerated than its hypothalamo-
neurohypophysial homologue vasopressin, which essentially 
controls water homeostasis. Interestingly, rare cases of auto-
immune hypothalamitis with vasopressin deficiency and dia-
betes insipidus have been repeatedly observed whereas any 
autoimmunity towards hypothalamic oxytocinergic neurons 
has never been reported. A similar reasoning may be applied 
to the members of the insulin family, IGF-2, IGF-1 and insulin 
itself. There is no report of autoimmunity against IGF-2, the 
dominant thymic self-peptide of the insulin family during foe-
tal life, whereas insulin is the primary autoantigen of type 1 
diabetes. Because of their close homology, thymic neuroen-
docrine self-antigens promote immunological cross-tolerance 
to their whole family, and tolerance to insulin was shown to 
be weaker in Igf2-/- mice than in wild-type mice (33). 
As already theorized by Burnet, the pathogenesis of 
 autoimmune diseases may first depend on a failure of self- 
tolerance and the development of ‘forbidden’ self-reactive 
immune clones (34). The progressive increase in immune 
complexity during evolution is associated with a higher inci-
dence of self-tolerance failures, most of them occurring in the 
human species. There is more and more evidence that a dys-
function in the mechanisms responsible for thymus-depend-
ent dominant and recessive self-tolerance is playing a primary 
role in the development of the autoimmune response toward 
many organs. Thymus transplantation from non-obese dia-
betic (NOD) mice, an animal model of type 1 diabetes, was 
shown to induce diabetes in normal recipients (35). Igf2 tran-
scription is deficient in the thymus of diabetes-prone Bio-
Breeding (DPBB) rats, another animal model of type 1 diabe-
tes, and such defect might contribute to both the absence of 
tolerance to β cells and the usual lymphopenia (including 
RT6+ Treg) observed in these animals (36). Mice with thymus-
restricted insulin defect develop strong proinsulin-specific 
T-cell reactivity (37). Loss-of-function Aire single mutations 
are responsible for a very rare autosomal recessive disease 
named autoimmune polyendocrinopathy, candidiasis and 
ectodermal dystrophy (APECED) or autoimmune polyglandu-
lar syndrome type 1 (APS-1). Depending on their genetic 
background, Aire-/- mice exhibit several signs of peripheral 
autoimmunity, which are associated with a significant 
decrease in the level of intrathymic neuroendocrine gene 
transcription, including those encoding oxytocin, insulin and 
IGF-2 (38, 39). Of note with regard to autoimmune thyroiditis, 
which is the most frequent autoimmune disease, all major 
thyroid-related antigens (thyroperoxydase, thyroglobulin and 
autotoxicity, the emergence of this sophisticated type of 
immune response exerted an evolutive pressure so powerful 
that, in concordance with Paul Ehrlich’s concept and predic-
tion of ‘horror autotoxicus’, novel structures and mechanisms 
appeared with a specific function in the setting-up of immu-
nological self-tolerance. Of note, the first thymus appeared in 
cartilaginous-jawed fishes but was preceded by thymus-like 
lympho-epithelial structures in the gill baskets of lamprey 
larvae as very recently demonstrated (23). These structures 
named ‘thymoids’ express the gene encoding forkhead box 
N4 (FOXN4), the orthologue of FOXN1. FOXN1 is the tran-
scription factor specific for the differentiation of thymus epi-
thelium in jawed vertebrates, and foxn1 mutation is respon-
sible for the nude phenotype in mouse. Therefore, FOXN1 
stands at a crucial place in the development of thymus epi-
thelium that is an absolute requirement for T-cell differentia-
tion. Moreover, the same study has provided strong evidence 
for a functional analogy between VLR assembly in these thy-
moids and TCR recombination in the thymus. This important 
discovery opens the question about the potential existence 
of autoimmune-like responses in jawless vertebrates.
Two essential and closely associated mechanisms are 
responsible for ensuring the thymus-dependent central arm 
of self-tolerance: 1) negative selection of self-reactive T cells 
that are stochastically generated by recombinase-dependent 
generation of TCR diversity in the thymus (recessive toler-
ance), and 2) positive selection of self-specific nTreg, which 
are able to inactivate in periphery self-reactive T cells having 
escaped thymic negative selection (dominant tolerance). 
Today, the major unresolved question is to understand the 
precise mechanisms by which the same associations of self-
antigens and thymic major histocompatibility complex (MHC) 
proteins are able to mediate both dominant and recessive 
self-tolerance (reviewed and discussed in 24). 
Another question has long concerned the nature of self 
that is presented in the thymus to differentiating T cells dur-
ing foetal life. Since its formulation some 75 years ago, ‘self’ 
has been a seminal word coined in immunological language 
as a fecund metaphor with some equivocal correlations to 
philosophy and neurocognitive sciences. For unknown rea-
sons, there was no serious attempt to elucidate the precise 
identity of self before a series of consecutive studies in the 
late 1980s and in the 1990s (7, 25-30). Our personal contribu-
tion in this field was to define the biochemical nature of the 
neuroendocrine self. First, thymic neuroendocrine self-anti-
gens usually correspond to peptide sequences that have 
been mostly conserved throughout evolution of their related 
protein family. Second, a hierarchy characterizes their expres-
sion profile in the thymus as one dominant member synthe-
sized in thymus epithelium represents its related neuro-
endocrine family in front of differentiating T lymphocytes 
(i.e. oxytocin for the neurohypophysial family, neurokinin A 
for tachykinins, neurotensin for neuromedins, corticostatin 
for somatostatins, and insulin-like growth factor 2 [IGF-2] for 
the insulin family). This hierarchical pattern is meaningful 
because the strength of immunological tolerance to a protein 
is proportional to its intrathymic concentration (31). Third, fol-
lowing Aire-regulated gene transcription, thymic neuroendo-
crine precursors are not processed according to the classic 
model of neurosecretion but undergo an antigen process-
ing for presentation by, or in association with, thymic MHC 
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Today, the restoration of thymus function appears as an 
important objective in the elderly, as well as in patients suf-
fering with AIDS or several hematological diseases (53, 54). 
It can now be anticipated that GH, IGF-1, GH secretagogues 
(such as ghrelin), GH and ghrelin receptor agonists, as well as 
other thymus-specific growth factors will be used in the near 
future for regenerating thymopoiesis and thymus tolerogenic 
function as well as, secondarily, several immune functions 
including responses to vaccines in aged and other immuno-
compromised patients.
In conclusion, as discussed in this short overview, a novel 
era is now widely open for objective clinical investigation of 
thymus function in a variety of immune and infectious dis-
eases. Moreover, the pharmacological manipulation of both 
thymus-dependent thymopoietic and tolerogenic function 
will provide the scientific community with innovative strate-
gies for the treatment of a large number of immune- mediated 
disorders. 
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